Correlation Between MedPacto and Sk Biopharmaceutica
Can any of the company-specific risk be diversified away by investing in both MedPacto and Sk Biopharmaceutica at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MedPacto and Sk Biopharmaceutica into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MedPacto and Sk Biopharmaceuticals Co, you can compare the effects of market volatilities on MedPacto and Sk Biopharmaceutica and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MedPacto with a short position of Sk Biopharmaceutica. Check out your portfolio center. Please also check ongoing floating volatility patterns of MedPacto and Sk Biopharmaceutica.
Diversification Opportunities for MedPacto and Sk Biopharmaceutica
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between MedPacto and 326030 is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding MedPacto and Sk Biopharmaceuticals Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sk Biopharmaceuticals and MedPacto is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MedPacto are associated (or correlated) with Sk Biopharmaceutica. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sk Biopharmaceuticals has no effect on the direction of MedPacto i.e., MedPacto and Sk Biopharmaceutica go up and down completely randomly.
Pair Corralation between MedPacto and Sk Biopharmaceutica
Assuming the 90 days trading horizon MedPacto is expected to under-perform the Sk Biopharmaceutica. In addition to that, MedPacto is 1.74 times more volatile than Sk Biopharmaceuticals Co. It trades about -0.03 of its total potential returns per unit of risk. Sk Biopharmaceuticals Co is currently generating about 0.04 per unit of volatility. If you would invest 7,090,000 in Sk Biopharmaceuticals Co on August 28, 2024 and sell it today you would earn a total of 3,000,000 from holding Sk Biopharmaceuticals Co or generate 42.31% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
MedPacto vs. Sk Biopharmaceuticals Co
Performance |
Timeline |
MedPacto |
Sk Biopharmaceuticals |
MedPacto and Sk Biopharmaceutica Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with MedPacto and Sk Biopharmaceutica
The main advantage of trading using opposite MedPacto and Sk Biopharmaceutica positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MedPacto position performs unexpectedly, Sk Biopharmaceutica can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sk Biopharmaceutica will offset losses from the drop in Sk Biopharmaceutica's long position.The idea behind MedPacto and Sk Biopharmaceuticals Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |